JP2015535077A5 - - Google Patents

Info

Publication number

JP2015535077A5

JP2015535077A5 JP2015537847A JP2015537847A JP2015535077A5 JP 2015535077 A5 JP2015535077 A5 JP 2015535077A5 JP 2015537847 A JP2015537847 A JP 2015537847A JP 2015537847 A JP2015537847 A JP 2015537847A JP 2015535077 A5 JP2015535077 A5 JP 2015535077A5

Authority

JP

Japan

Prior art keywords

conductive support

hydrogel

biosensor

functional fragment

test strip

Prior art date

2013-10-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000017 hydrogel Substances 0.000 claims description 75
• 238000000034 method Methods 0.000 claims description 39
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 38
• 229940072056 alginate Drugs 0.000 claims description 38
• 235000010443 alginic acid Nutrition 0.000 claims description 38
• 229920000615 alginic acid Polymers 0.000 claims description 38
• 239000000523 sample Substances 0.000 claims description 38
• 108090000790 Enzymes Proteins 0.000 claims description 33
• 102000004190 Enzymes Human genes 0.000 claims description 33
• 239000012634 fragment Substances 0.000 claims description 33
• 210000001124 body fluid Anatomy 0.000 claims description 29
• 230000002503 metabolic effect Effects 0.000 claims description 26
• 235000001014 amino acid Nutrition 0.000 claims description 23
• 150000001413 amino acids Chemical class 0.000 claims description 23
• 239000010839 body fluid Substances 0.000 claims description 22
• 239000003638 chemical reducing agent Substances 0.000 claims description 18
• 108010078226 phenylalanine oxidase Proteins 0.000 claims description 9
• 230000001580 bacterial effect Effects 0.000 claims description 6
• 208000030159 metabolic disease Diseases 0.000 claims description 6
• 230000003647 oxidation Effects 0.000 claims description 6
• 238000007254 oxidation reaction Methods 0.000 claims description 6
• 239000007787 solid Substances 0.000 claims description 6
• 241000626621 Geobacillus Species 0.000 claims description 4
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
• 229920000642 polymer Polymers 0.000 claims description 4
• 239000000758 substrate Substances 0.000 claims description 4
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
• HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 206010020575 Hyperammonaemia Diseases 0.000 claims description 3
• 208000030162 Maple syrup disease Diseases 0.000 claims description 3
• 201000011252 Phenylketonuria Diseases 0.000 claims description 3
• HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
• HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
• 210000004369 blood Anatomy 0.000 claims description 3
• 239000008280 blood Substances 0.000 claims description 3
• 208000024393 maple syrup urine disease Diseases 0.000 claims description 3
• 210000002966 serum Anatomy 0.000 claims description 3
• GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 2
• IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-Dihydroxybenzaldehyde Natural products OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims description 2
• RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims description 2
• 108010031025 Alanine Dehydrogenase Proteins 0.000 claims description 2
• 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 claims description 2
• 101710088194 Dehydrogenase Proteins 0.000 claims description 2
• 229920002307 Dextran Polymers 0.000 claims description 2
• 102000016901 Glutamate dehydrogenase Human genes 0.000 claims description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
• 108010028658 Leucine Dehydrogenase Proteins 0.000 claims description 2
• 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 2
• 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 2
• 108090000854 Oxidoreductases Proteins 0.000 claims description 2
• 102000004316 Oxidoreductases Human genes 0.000 claims description 2
• 108010092464 Urate Oxidase Proteins 0.000 claims description 2
• 239000003153 chemical reaction reagent Substances 0.000 claims description 2
• 239000013068 control sample Substances 0.000 claims description 2
• 230000001419 dependent effect Effects 0.000 claims description 2
• 238000001962 electrophoresis Methods 0.000 claims description 2
• 229960000907 methylthioninium chloride Drugs 0.000 claims description 2
• 239000013074 reference sample Substances 0.000 claims description 2
• KUUVQVSHGLHAKZ-UHFFFAOYSA-N thionine Chemical group C=1C=CC=CSC=CC=1 KUUVQVSHGLHAKZ-UHFFFAOYSA-N 0.000 claims description 2
• 229950003937 tolonium Drugs 0.000 claims description 2
• HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 claims description 2
• 210000002700 urine Anatomy 0.000 claims description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
• 208000016097 disease of metabolism Diseases 0.000 description 3
• 239000000178 monomer Substances 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 229910052709 silver Inorganic materials 0.000 description 3
• 239000004332 silver Substances 0.000 description 3
• 239000000661 sodium alginate Substances 0.000 description 3
• 235000010413 sodium alginate Nutrition 0.000 description 3
• 229940005550 sodium alginate Drugs 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 239000004971 Cross linker Substances 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
• FRTYOTPCWDRFAE-UHFFFAOYSA-N 3-amino-2-tert-butylhex-2-enamide Chemical compound CCCC(N)=C(C(N)=O)C(C)(C)C FRTYOTPCWDRFAE-UHFFFAOYSA-N 0.000 description 1
• WZISPVCKWGNITO-UHFFFAOYSA-N 4-(diethylamino)-2-methylidenebutanamide Chemical compound CCN(CC)CCC(=C)C(N)=O WZISPVCKWGNITO-UHFFFAOYSA-N 0.000 description 1
• 0 CC*1(C*C)CC(CC)=C(*)C1 Chemical compound CC*1(C*C)CC(CC)=C(*)C1 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
• OVOHQBZVYSGOHD-UHFFFAOYSA-N P(=O)(OCC)(O)O.C(C=C)(=O)N Chemical compound P(=O)(OCC)(O)O.C(C=C)(=O)N OVOHQBZVYSGOHD-UHFFFAOYSA-N 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• 229910021607 Silver chloride Inorganic materials 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 239000005388 borosilicate glass Substances 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000004020 conductor Substances 0.000 description 1
• 238000007306 functionalization reaction Methods 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
• AWGZKFQMWZYCHF-UHFFFAOYSA-N n-octylprop-2-enamide Chemical compound CCCCCCCCNC(=O)C=C AWGZKFQMWZYCHF-UHFFFAOYSA-N 0.000 description 1
• BPCNEKWROYSOLT-UHFFFAOYSA-N n-phenylprop-2-enamide Chemical compound C=CC(=O)NC1=CC=CC=C1 BPCNEKWROYSOLT-UHFFFAOYSA-N 0.000 description 1
• XFHJDMUEHUHAJW-UHFFFAOYSA-N n-tert-butylprop-2-enamide Chemical compound CC(C)(C)NC(=O)C=C XFHJDMUEHUHAJW-UHFFFAOYSA-N 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 235000012431 wafers Nutrition 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1